Clinical Trials Directory

Trials / Completed

CompletedNCT00611949

Comparison of 2 Vials of Components of a Synthetic Geranium Oil

EPT 101: New Geranium Oil Formulation for the Treatment of Neuropathy Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine which component of an artificial geranium oil helps to reduce your neuropathy pain.

Detailed description

EPT 101 is a double-blind successive crossover study designed to determine which components of a synthetic geranium oil provide analgesic relief, with the objective of identifying and purifying the active substance. This is not a hypothesis-generating trial, nor is it confirming a hypothesis. The trial uses human volunteers in an efficacy-directed decomposition of a complex mixture. Patients with a diagnosis of neuralgia or neuropathy who respond to geranium oil will test two vials of components of a synthetic geranium oil for application to the maximally painful area in succession. They will treat their condition in the clinic and fill out a patient diary on separate days. The primary objective is the patient opinion of which vial has greatest analgesic efficacy. Efficacy will be measured primarily by reduction in pain intensity summed over the first two hours, compared with the pain intensity during the 30 minutes preceding application. Following the comparison of the first two vials, the vial judged efficacious will be decomposed into two further vials and the patients will repeat the evaluation described above. At least eight pair-wise comparisons will be required to determine and confirm which of the 100+ ingredients of a synthetic geranium oil are analgesic, provided there is only one such ingredient.

Conditions

Interventions

TypeNameDescription
OTHERGeranium oil2 applications of topical oil per week for 2 weeks

Timeline

Start date
2002-05-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2008-02-11
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00611949. Inclusion in this directory is not an endorsement.